window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : July 29, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

biologics manufacturing

  • Drug Delivery & Formulation,Drug Discovery & Development,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics,Research & Development

    ProBioGen and VarmX partner on second Factor X candidate

    ProBioGen and VarmX have entered a collaboration to develop a [...]

    July 29, 2026
  • Advanced Therapies,Biotech & Pharma Business,Manufacturing & Supply Chain,Research & Development

    Icosagen completes €45M biologics manufacturing expansion

    Estonian biotechnology company Icosagen has completed a €45 million expansion [...]

    July 2, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Manufacturing & Supply Chain

    Microbial manufacturing enters a new era of scale and complexity

    As demand grows for increasingly complex biologics, microbial manufacturing is [...]

    June 18, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Manufacturing & Supply Chain

    Lonza expands DNA-to-IND offering to accelerate biologics development timelines

    Lonza has expanded its integrated DNA-to-IND biologics development offering, introducing [...]

    June 8, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Manufacturing & Supply Chain,Therapeutic Areas

    Anixa Biosciences advances breast cancer vaccine toward Phase 2 with Cytovance manufacturing deal

    Anixa Biosciences is advancing its breast cancer vaccine programme towards [...]

    May 5, 2026
  • Advanced Therapies,Drug Discovery & Development,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics,Therapeutic Areas

    ImmuneOncia Therapeutics and Lonza agree manufacturing partnership for PD-L1 antibody Danburstotug

    ImmuneOncia Therapeutics and Lonza have entered into a manufacturing collaboration [...]

    May 5, 2026
  • Biotech & Pharma Business,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    Vetter recognised as 2026 CDMO Leadership Awards winner in finished dose category

    Vetter has been named winner in the Finished Dose category [...]

    May 5, 2026
  • Drug Discovery & Development,Manufacturing & Supply Chain,Opinion & Events,Pharmaceuticals and therapeutics

    Fujifilm Biotechnologies unveils ShunzymeX purification technology for biologics

    FUJIFILM Biotechnologies has unveiled ShunzymeX, a purification technology designed to [...]

    May 5, 2026
  • Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    Fujifilm invests £400M in UK biomanufacturing expansion with new Teesside single-use facility

    FUJIFILM Biotechnologies has opened a £400M biomanufacturing and process development [...]

    May 5, 2026
  • Advanced Therapies,Drug Discovery & Development,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    RION partners with Lonza to scale manufacturing of exosome-based therapeutics

    RION, a commercial and clinical-stage regenerative medicine company pioneering platelet-derived [...]

    May 5, 2026

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • AI-driven antibody discovery could create $7bn market for life science tools
    Categories: Digital & Data, Drug Delivery & Formulation, Research & Development
  • Pace Life Sciences passes FDA inspection at North Carolina facility
    Categories: Clinical & Regulatory, Manufacturing & Supply Chain
  • CAMP4 wins Australian clearance to begin Phase 1/2 trial of SYNGAP1 therapy
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top